ABIOMED, Inc. ABMD Income Statement

Abiomed, inc. (ABMD)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
Product revenue
-	-	-	-	-	-	-	-	-	-	504,491	474,637	445,195	414,492	385,657	359,083	329,520	303,119	279,296	254,716	229,950	212,642	196,817	189,331	183,280	176,574	168,545	161,576	157,614	151,315	144,935	136,767	125,286	116,152	111,335	105,242	99,837	0	0	0
Funded research and development
-	-	-	-	-	-	-	-	-	-	154	140	109	89	45	23	23	24	57	216	361	545	560	453	363	310	394	435	510	479	807	1,036	1,089	1,408	1,271	1,262	1,314	0	0	0
Revenue
840,882	841,305	820,284	797,088	769,432	736,787	690,246	641,291	593,749	543,993	504,645	474,777	445,304	414,581	385,702	359,106	329,543	303,143	279,353	254,932	230,311	213,187	197,377	189,784	183,643	176,884	168,939	162,011	158,124	151,794	145,742	137,803	126,375	117,560	112,606	106,504	101,151	0	0	0
Costs and expenses:
Cost of revenue
151,305	146,784	140,811	135,790	129,567	124,817	115,788	107,569	98,581	87,744	81,737	77,419	70,627	66,029	59,786	54,621	50,419	46,562	43,656	41,124	39,945	39,253	38,873	38,288	37,322	36,034	34,706	32,873	31,596	29,556	27,705	26,062	24,507	23,569	22,727	22,584	21,977	0	0	0
Research and development
98,759	98,962	97,272	96,020	93,503	89,225	82,966	79,639	75,297	70,352	68,995	67,657	66,386	64,286	61,692	55,209	49,759	45,387	39,997	37,121	35,973	34,040	33,454	32,482	30,707	29,609	28,089	26,222	25,647	26,061	25,942	26,547	27,159	26,766	27,218	27,348	26,677	0	0	0
Selling, general and administrative
341,600	339,004	333,550	326,489	321,550	315,755	302,091	283,276	262,734	247,333	234,712	227,718	218,153	203,309	191,227	177,970	164,261	153,540	141,826	131,452	125,727	119,913	114,138	110,882	107,251	102,424	99,003	91,241	84,227	80,361	76,602	74,488	71,711	68,571	66,979	64,710	62,287	0	0	0
Amortization of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	111	463	825	1,204	1,478	1,487	1,420	1,413	1,395	0	0	0
Costs and Expenses, Total
591,664	584,750	571,633	558,299	544,620	529,797	500,845	470,484	436,612	405,429	385,444	372,794	355,166	333,624	312,705	287,800	264,439	245,489	225,479	209,697	201,645	193,206	186,465	181,652	175,280	168,067	161,798	150,336	141,581	136,441	131,074	128,301	124,855	120,393	118,344	116,055	112,336	0	0	0
Income from operations
249,219	256,555	248,651	238,789	224,812	206,990	189,401	170,807	157,137	138,564	119,201	101,983	90,138	80,957	72,997	71,306	65,104	57,654	53,874	45,235	28,666	19,981	10,912	8,132	8,363	8,817	7,141	11,675	16,543	15,353	14,668	9,502	1,520	-2,833	-5,738	-9,551	-11,185	0	0	0
Other income:
Investment income, net
12,167	11,836	10,925	9,664	8,166	6,700	5,494	4,604	3,688	2,871	2,359	1,920	1,554	1,254	881	601	395	277	241	215	196	168	157	146	118	71	35	11	-7	1	-2	-9	-3	4	10	15	9	0	0	0
Other (expense) income, net
-4,561	47,651	23,960	69,558	30,382	-353	-414	-279	-388	-149	-102	-193	-349	3	8	209	339	52	71	-55	-97	6	36	81	49	20	324	309	326	296	11	86	9	-102	-111	-305	-143	0	0	0
Gain on sale of WorldHeart stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	456	0	0	0
Gain on settlement of investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Nonoperating Income (Expense), Total
7,607	59,487	34,885	79,222	38,548	6,347	5,080	4,325	3,300	2,722	2,257	1,727	1,205	1,257	889	810	734	329	312	160	99	174	193	227	167	91	359	320	319	297	1,026	1,094	1,023	919	-101	-73	322	0	0	0
Income before income taxes
256,825	316,042	283,536	318,011	263,360	213,337	194,481	175,132	160,437	141,286	121,458	103,710	91,343	82,214	73,886	72,116	65,838	57,983	54,186	45,395	28,765	20,155	11,105	8,359	8,530	8,908	7,500	11,995	16,862	15,650	15,694	10,596	2,543	-1,914	-5,839	-9,624	-10,863	0	0	0
Income tax provision
53,815	70,869	62,669	60,069	4,269	-8,640	3,968	10,249	48,267	51,064	29,250	27,130	39,227	33,999	30,548	29,918	27,691	-68,040	-73,966	-78,861	-84,923	1,719	960	994	1,179	1,437	1,738	1,823	1,848	1,811	1,618	1,388	1,048	930	728	745	892	0	0	0
Net income
203,009	245,172	220,817	257,873	259,016	221,902	190,486	164,862	112,170	90,222	92,208	76,580	52,116	48,215	43,338	42,198	38,147	126,023	128,152	124,256	113,688	18,436	10,145	7,365	7,351	7,471	5,762	10,172	15,014	13,839	14,076	9,208	1,495	-2,844	-6,567	-10,369	-11,755	0	0	0
Basic net income per share
0.71	1.53	0.29	1.97	1.64	1.00	1.11	2.02	0.83	0.30	0.56	0.85	0.34	0.36	0.21	0.30	0.26	0.25	0.18	0.21	2.44	0.31	0.09	-0.04	0.09	0.11	0.03	-0.04	0.09	0.07	0.14	0.08	0.06	0.08	0.02	-0.12	-	-0.02	-0.09	-
Basic weighted average shares outstanding
45,042	45,140	45,319	45,215	45,091	45,046	44,961	44,546	44,329	44,247	44,141	43,895	43,581	43,431	43,129	42,811	42,465	42,427	42,228	41,696	41,162	40,856	40,448	40,062	39,806	39,592	39,260	38,678	38,460	39,417	39,431	39,144	38,474	38,498	38,256	38,268	-	37,195	37,156	-
Diluted net income per share
0.70	1.51	0.28	1.93	1.60	0.97	1.09	1.95	0.80	0.29	0.54	0.82	0.34	0.34	0.20	0.29	0.25	0.23	0.17	0.20	2.30	0.30	0.09	-0.04	0.08	0.11	0.03	-0.04	0.09	0.07	0.13	0.08	0.07	0.07	0.02	-0.12	-	-0.02	-0.09	-
Diluted weighted average shares outstanding
45,565	45,695	45,912	46,092	46,146	46,136	46,153	46,169	46,221	45,869	45,698	45,608	44,104	44,770	44,580	45,178	45,299	44,949	44,922	44,410	46,247	42,884	42,239	40,062	44,683	41,726	41,337	38,678	40,072	40,865	41,722	41,549	42,784	40,270	39,366	38,268	-	37,195	37,156	-
Basic and diluted net loss per share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.16
Weighted average shares outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37,086